Sixteen months after the end of treatment, Peter reported that he was still doing well in a
follow-up interview and that there had not been any relapses concerning the use of CSAI. He has
been abstinent for three years. He reported to have improved his listening to his “inner
supporter” and relying on himself in dealing with frustrating situations in order to find problem-
oriented solutions. By then, it had become clear to him that Christmas is a difficult time because
his frustrated needs for comfort and appreciation are stronger at this time of the year. He saw that
his relapse plan worked and that he could confide in his wife and talk to her about his feelings.
After the end of treatment, Peter contacted the therapy institute once to get medication
2017 (nalmefene, 18 mg) to take as needed. Nalmefene is an antagonist at the µ-o
id receptor and
August 31 agonist at the κ-o
id receptor. It has recently been approved for the use as an on demand
04:05 medication in alcohol dependence in Germany and has shown some effectiveness in the at
Berlin] treatment of other behavioral disorders (see e.g. Grant, Odlaug, Potenza, Hollander, & Kim, [FU 2010). Peter took the medication once when he felt a strong sexual urge to look for CSAI on the
by
Internet. Ultimately, he managed not to act on these impulses and reported feeling confident
Downloaded about not using CSAI in the future.
